Surinder Kaur - Concepedia

Author

Surinder Kaur

Also Known As

Brian Gastman, Dr. Surinder Kaur, Rebecca Kandiyali, Robert Hawker, S Kaur, S. Kaur, SURINDER KAUR, Surinder Kaur, Surinder. Kaur, Susan D. Spencer

166

Publications

7.6K

Citations

H-Index

133

Concepts

All Affiliations

Northwestern University Bristol-Myers Squibb (United States)Biogen (United States)United States Food and Drug Administration Pfizer (United States)

About

Surinder Kaur is an author at Northwestern University specializing in medicine, immunology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	38	4.3K
2	Natural Sciences	10	10	628
3	Engineering	7	7	489
4	Public Health	1	1	13
5	Social Sciences	1	1	26

Surinder Kaur

Publications

6.6K

Citations

H-Index

Page 1

	Year	Citations
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates Ben‐Quan Shen, Keyang Xu, Luna Liu, Nature Biotechnology ImmunoengineeringImmunologyBioconjugationAntibody EngineeringImmunotherapeutics	2012	977
Therapist-delivered internet psychotherapy for depression in primary care: a randomised controlled trial Glyn Lewis, Surinder Kaur, Nicola Wiles, The Lancet Family MedicinePrimary CareMental Health MonitoringPsychiatryMedicine	2009	396
AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia Erika Krasnickas Keeton, Kristen McEachern, Keith Dillman, Blood	2013	240
Bioanalytical Assay Strategies for The Development of Antibody–Drug Conjugate Biotherapeutics Surinder Kaur, Keyang Xu, Ola M. Saad, Bioanalysis Immunocytochemical TechniqueImmunologyImmunotherapeuticsTumor BiologyImmunoassays	2013	227
Role of the Akt pathway in mRNA translation of interferon-stimulated genes Surinder Kaur, Antonella Sassano, Blazej Dolniak, Proceedings of the National Academy of Sciences Molecular RegulationImmunologyMrna TranslationMtor PathwayTranscriptional Regulation	2008	205
Impact of Drug Conjugation on Pharmacokinetics and Tissue Distribution of Anti-STEAP1 Antibody–Drug Conjugates in Rats C. Andrew Boswell, Eduardo E. Mundo, Crystal Zhang, Bioconjugate Chemistry NanotherapeuticsLocal PharmacologyImmunologyCellular PharmacologyPharmacotherapy	2011	200
Characterization of intact antibody–drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography–mass spectrometry Keyang Xu, Luna Liu, Ola M. Saad, Analytical Biochemistry MedicineIntact Antibody–drug ConjugatesBioanalysisMass SpectrometryImmunology	2011	189
Preclinical safety profile of trastuzumab emtansine (T-DM1): Mechanism of action of its cytotoxic component retained with improved tolerability Kirsten Achilles Poon, Kelly M. Flagella, Joseph C. Beyer, Toxicology and Applied Pharmacology Breast OncologyImmunologyCytotoxic ComponentImmunotherapeuticsUnconjugated Dm1	2013	189
Primary‐care patients’ expectations and experiences of online cognitive behavioural therapy for depression: a qualitative study Angela Beattie, Alison Shaw, Surinder Kaur Health Expectations	2009	185
Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells Nathalie Carayol, Eliza Vakana, Antonella Sassano, Proceedings of the National Academy of Sciences ApoptosisImmunologyCell DeathMtor PathwayTumor Biology	2010	176

Page 1